Drug Threats in the United States: 2019 Update

Similar documents
Synthetic Drug Threats in the United States: 2018 Update

Primer on Synthetic Opioids I/S Brian Dempsey

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Drug Trends &Trafficking I/S Brian Dempsey

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Data Tables

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

WEDINOS Headlines 6,452. wedinos.org 5,806 BULLETIN. Samples. received. Samples. received. Samples. analysed. Samples. rejected

The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Trend Report: Q Synthetic Cannabinoids in the United States

Forensic Toxicology Findings in DRDs. Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Texas Sentinel Community Site Appendix Data Tables, 2015 NDEWS Coordinating Center

Trends in Opioid Availability and Abuse DEA Philadelphia Field Division April 2018

Subject Matter Analysis. Novel Psychoactive Substances Legislative and Regulatory Update

Substances under Surveillance

National Drug Early Warning System (NDEWS) Los Angeles County Sentinel Community Site Appendix Data Tables, 2015

39 th Expert Committee on Drug Dependence Process and recommendations

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

wedinos.org WEDINOS Headlines 6,056 Synthetic Cannabinoid Receptor Agonists and the Law 5,058

Fentanyls. Reference materials LGC Quality ISO 9001 ISO/IEC ISO Guide 34 GMP/GLP ISO ISO/IEC 17043

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Data Tables

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Conventional and emerging drugs of abuse: the current situation

SEWPROF Roundtable Spain

61 st CND session 5(a) Changes in the scope of control of substances - Control Regimes -

Fentanils in Europe: perspective from the EU EWS

A handful of dangerous new legal drugs has public health experts worried

Chicago Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts

Drug Trends and Trafficking in Montana and Beyond

Heroin/Fentanyl/Cocaine Related Deaths in Cuyahoga County

Analytic Techniques Utilisedfor Drug Checking

Palm Beach County Substance Awareness Coalition. Drug Abuse Trends In Palm Beach County, Florida Annual Report: July 2017

Philadelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

(U) Cocaine/Fentanyl Combination in Pennsylvania

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

Denver Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

National Drug Early Warning System (NDEWS,

Drug Checking: l esperienza ed i dati. Alberto SALOMONE

Forensic Toxicology Scope of Testing and Detection Limits

Clinical Toxicology: An Update

Heroin/Fentanyl/Cocaine Related Deaths in Cuyahoga County

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Texas Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Los Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Southeastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs

Designer Drugs Is Your Drug Testing Program Keeping Up? 2

The South Florida Report June 2013

wedinos.org WEDINOS Headlines 5,300 Cathinones 4, Substances BULLETIN Samples received Samples analysed Samples rejected

25 Most Frequently Identified Drugs * NFLIS Laboratories. Disclosure. Objectives. Deadly in Design: New (Novel) Psychoactive Substances Update

Pills, Powders, Potions and Paraphernalia

Miami Dade County Substance Abuse Trends and Needs Assessment 2017

Wayne County (Detroit Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017

BULLETIN. This quarter (October 2015 to December 2015) Samples. analysed. 53 Samples pending. f 41. Samples. rejected

GLOBAL S MART UPDATE. Understanding the synthetic drug market: the NPS factor VOLUME 19. March

Lisa Booze, PharmD, CSPI

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Proposal for a COUNCIL DECISION

Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB- PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA

Community Epidemiology Report November 2014

Ethyl Alcohol. Phencyclidine (PCP) PCP Analogs Phenethylamines/ Piperazines Tryptamines. Halogenated Helium Hydrocarbon Nitrous Oxide

THE EXPANDING REACH OF THE DESIGNER DRUG MOVEMENT IN 2011: CHALLENGES FOR FORENSIC TOXICOLOGY & CHEMISTRY

Drug Early Warning Signals (DEWS): Operation PAR North Fort Myers, Florida

Illicit Opioid and Methamphetamine Trends in Maine

New psychoactive substances in Belgium: current status

An Overview of Drug Trends in the U.S. Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin

T-9 GC-MS. Solid Science Creative Ideas Innovative Products

BULLETIN WEDINOS

E/CN.7/2015/CRP.10 * * 9 December English only V (E) * The present document is reproduced in the form in which it was received.

SA 15 REPORT ON THE ANALYZED SUBSTANCES IN SPAIN BY ENERGY CONTROL DURING 2015 A PROGRAM OF THE ASSOCIATION:

New patterns of drug use in Hungary

2014 Key Australian findings: psychostimulant drug market

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

The law is changing. wedinos.org. WEDINOS Headlines 4,824 3, Substances identified in either combination or isolation.

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

DRUG ABUSE: NATIONAL AND LOCAL PERSPECTIVES. Florence, Alabama June 2018 Brent Ashton Supervisory Special Agent, DEA Birmingham District Office

Future Analytical Considerations

DRUGS AND THE INTERNET

Drug Abuse Trends in Miami-Dade County Florida: June 2015

NPS New Psychoactive Substances

DRUG OVERDOSE DEATHS ANALYSIS

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Jane Maxwell, UT Addiction Research Institute, Drug Trends: Old Drugs and New Problems - New Drugs and New Problems

Ecstasy and Related Drugs Reporting System: 2016 Findings

Addiction Medicine Update

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Transcription:

Drug Threats in the United States: 209 Update J I L L M. H E A D S P E C I A L T E S T I N G A N D R E S E A R C H L A B O R AT O R Y D R U G E N F O R C E M E N T A D M I N I S T R AT I O N

Objectives. Overview of the DEA Emerging Trends & Reference Materials Programs 2. Emerging Threat Report data for CY208. Synthetic Cannabinoids 2. Synthetic Cathinones 3., -related compounds and new synthetic opioids 4. Other NPS classes 3. Seized drug composition and mixtures containing fentanyl

Emerging Trends and Reference Material Programs. Analysis of domestic and foreign drug seizures 2. Research and method development for identification and quantitation 3. Authentication of reference materials 4. Structural Elucidation of unknown drugs 5. Authors SWGDRUG monographs 6. Monitors past/current trends to predict future needs 7. Publishes Emerging Threat Report

Emerging Threats New Psychoactive Substances (NPS) A new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the UN drug conventions, but which may pose a public health threat Synthetic Cannabinoids Substituted Cathinones Hallucinogens Synthetic Opioids Benzodiazepines Plant-Derived Highs

Forensic Chemistry Analysis WHAT IT IS Seized drug samples Parent drug WHAT IT IS NOT Biological samples Toxicological samples Metabolites

Data Sources DEA Reporting Laboratory Information Management System (LIMS) Seized: 0/0/208 2/3/208, Analyzed by 2/3/208 Considerations Backlogs Availability of reference materials Excludes analyses performed at DEA Special Testing and Research Laboratory

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM PB-22 FUB-PB-22 FUB-AKB48 AB-FUBINACA 5F-EMB-PINACA 5F-AKB48 5Cl-AKB48 MDMB-FUBINACA MMB-220 AB-CHMINACA 4-CN-CUMYL-BUTINACA AB-PINACA NM220 MMB-FUBICA ADB-CHMINACA 5F-UR-44 FUB-44 5F-AMB MMB-CHMICA 5F-MDMB-PICA 5F-EDMB-PINACA ADB-FUBINACA FUB-AMB 5F-MDMB-PINACA 2 2 4 4 5 6 6 7 7 8 5 6 20 Synthetic Cannabinoids Seized and Identified by DEA between January, 208 to December 3, 208 7 526 synthetic cannabinoid identifications 5F-MDMB-PINACA and FUB-AMB was the most reported synthetic cannabinoids (64%) 25 different substances seized and identified 7 substances identified for the first time 63 72 Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/208 through 2/3/208 that were analyzed by 2/3/208. The data was retrieved on 0//209.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM α-php TH-PVP Pentedrone N,N-Dimethylpentylone 3,4-MDDMC 4-MEC 4-MeAPP Methylone 4'-Methyl-α-PHP α-pvp α-ppp Pentylone 4-Methylpentedrone Ethylone 4-F-α-PHP 4-CEC α-pihp 4-Cl-α-PVP Dibutylone N-Ethylhexedrone N-Ethylpentylone 2 2 3 3 3 3 5 7 7 2 28 29 Synthetic Cathinones Seized and Identified by DEA between January, 208 to December 3, 208 327 synthetic cathinone identifications N-Ethylpentylone was the most reported cathinone (62%) 22 different substances seized and identified 5 cathinones identified for the first time 204 Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/208 through 2/3/208 that were analyzed by 2/3/208. The data was retrieved on 0//209

and Synthetic Opioids

Pharmaceutical

Furanyl fentanyl Acetylfentanyl Valeryl fentanyl

Packaging

Tablets New Jersey AB-FUBINACA/ etizolam/fentanyl New York acetylfentanyl New Jersey

Other Forms Texas California Acetylfentanyl Nebraska

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Synthetic Opioids Seized in 205 Valeryl fentanyl 4-ANPP 8 β-hydroxythiofentanyl 2 Butyrylfentanyl 5 Acetylfentanyl 32 524 Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/205 through 2/3/205 that were analyzed by 2/3/206. The data was retrieved on 0/04/207.

-type substances Acetyl fentanyl Butyryl fentanyl Valeryl fentanyl (Pentanoyl fentanyl)

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Acetyl norfentanyl 3-Methylfentanyl 2 p-fluorobutyrylfentanyl 3 Benzylfentanyl 3 o-fluorofentanyl 4 Valerylfentanyl 0 Opioid & -like CY 206 Identifications 5 different substances seized and identified in 206 ~60% of these substances were seized and reported for the first time in 206 Butyryl fentanyl Acryl fentanyl Carfentanil 4-Fluoroisobutyrylfentanyl 4-ANPP 3 3 7 20 32 U-47700 50 Acetylfentanyl 2 Furanyl fentanyl 42 877 Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/206 through 2/3/206 that were analyzed by 2/3/206. The data was retrieved on 0/04/207.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM -type substances 3-Methylfentanyl 4-Fluoroisobutyrfentanyl β-hydroxythiofentanyl Carfentanil

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM U-49900 p-fluorobutyryl fentanyl o-methyl acetyl fentanyl 4'-Methyl acetyl fentanyl N-Methyl norfentanyl NPP Isopropyl U-47700 2-Thiofuranyl fentanyl Acryl fentanyl U-48800 despropionyl p-fluorofentanyl Benzyl fentanyl 3-Methylfentanyl Benzoyl fentanyl 2-Furanylbenzyl fentanyl Valeryl fentanyl Butyryl fentanyl Furanyl fentanyl Carfentanil U-47700 Methoxyacetylfentanyl Cyclopropylfentanyl 4-FiBF Acetylfentanyl 4-ANPP 2 3 4 4 6 7 7 8 0 3 6 27 35 37 42 59 6 09 88 25 Synthetic Opioids Seized and Identified by DEA in CY208 ~27% increase in identifications from CY207 26 different substances seized and identified 7 substances seized and identified for the first time 2723 Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/208 through 2/3/208 that were analyzed by 2/3/208. The data was retrieved on 0//209.

DRUG ENFORCEMENT ADMINISTRATION SPECIAL TESTING AND RESEARCH LABORATORY EMERGING TRENDS PROGRAM Hallucinogens Benzodiazepines 2C-I 2C 25C-NBOMe Flualprazolam Flubromazolam 2 4 25B-NBOMe Etizolam 35 25I-NBOMe 2 2C-B 4 Other Substance Unconfirmed 92 DBZP Piperazines 3 Mitragynine 2 3-MeO-PCP 7 2F-Deschloroketamine 3 2-Oxo-PCE 3 pfpp BZP TFMPP 4 6 9 MMMP 3 4-Fluoroamphetamine 2 Unknown 2 Yohimbine 2 3-Fluorophenmetrazine 5-MeO-DALT 5-MeO-DiPT DMAA Notes: ) This data was compiled from analytical results from the DEA laboratory system. It encompasses exhibits seized 0/0/208 through 2/3/208 that were analyzed by 2/3/208. The data was retrieved on 0//209.

A LOOK AT SEIZED DRUG MIXTURES

Mixtures Containing with Each identification was made in the same seized material May have also contained other substances (controlled or noncontrolled) Heroin # of Identifications 4228 Cocaine 42 Methamphetamine 208 Note: This data was acquired from exhibits analyzed by the DEA Laboratory System.

Substances Identified Weight Region Heroin Heroin (2.5%) Heroin (5.4%) (4.5%) Heroin (8%) (3.7%) Heroin (2%) (2%) Diphenhydramine Heroin Procaine Heroin Tramadol Quinine Heroin (3.9%) Tramadol Caffeine Procaine Quinine 7986g powder South Central Region 6.9g powder South Central Region.9g powder Mid-Atlantic Region 49g powder 89g powder 495g powder North Central Region North Central Region Northeastern Region 0.5g powder Northeastern Region 998g (brick) Northeastern Region Heroin and Mixtures Note: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/208 through /5/209.

Substances Identified Weight Region Cocaine Heroin Cocaine Caffeine Quinine Ibuprofen Lidocaine Heroin Cocaine Quinine Salicylic Acid Caffeine Cocaine Hydrochloride Phenacetin 0.86g powder Southeastern Region Residue (paraphernalia) Mid-Atlantic Region 4.6g powder Southeastern Region 996g powder Southwestern Region Cocaine and Mixtures Note: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/208 through /5/209.

Substances Identified Weight Region Heroin Methamphetamine Xylazine Quinine Caffeine Diphenhydramine Cocaine Methamphetamine 06-monoacetylmorphine Noscapine PTHIT (4.6%) Tramadol Ketamine Methamphetamine Noscapine Dipyrone (0.8%) Heroin Methamphetamine Acetaminophen Caffeine Lidocaine 3.3g powder North Central Region Residue (scale) 53g powder Southwestern Region Southwestern Region 5.2g tablets Northeastern Region Methamphetamine and Mixtures Note: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/208 through /5/209.

Substances Identified Weight Region Cocaine Heroin 2-Furanyl fentanyl Caffeine Quinine Benzocaine PTHIT (.2%) Heroin 5F-MDMB-PINACA Cyclopropyl fentanyl Cocaine Lidocaine Caffeine Heroin (.5%) 4-Chloroethcathinone U-47700 2-Furanyl fentanyl Quinine Diphenhydramine Etizolam 45.2g powder Southeastern Region 28g powder 49g powder Southeastern Region North Central Region Complex Mixtures Note: This data was acquired from exhibits analyzed by the DEA Laboratory System between 9/2/208 through /5/209.

Is marijuana being mixed or laced with fentanyl? Few identifications of THC and fentanyl Majority were residue (i.e. scales, paraphernalia) None were described as plant material No indications of marijuana and fentanyl identified in the data set reviewed and Marijuana Note: This data was acquired from exhibits analyzed by the DEA Laboratory System.

Laboratory Resources: Update Searchable Libraries: IR Library Version 2.0 Updated 2/8/209 MS Library Version 2.0 Updated /3/9 Drug Monographs Regularly updated

Summary 22 NPS were identified for the first time in 208 which equates to approximately one new substance approximately every two and a half weeks. Approximately 33% of the synthetic opioids identified were seized and identified for the first time in 208. Seized drug analyses can be a useful tool in understanding complex drug mixtures and their relationship to toxicological results.

Thank You! Jill M. Head Supervisory Chemist United States Drug Enforcement Administration Special Testing and Research Laboratory Jill.M.Head@usdoj.gov 703-668-3300